Vitamin D levels in Smith-Lemli-Opitz syndrome
- PMID: 28796426
- PMCID: PMC5603413
- DOI: 10.1002/ajmg.a.38361
Vitamin D levels in Smith-Lemli-Opitz syndrome
Abstract
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive congenital malformation syndrome caused by mutations in the 7-dehydrocholesterol reductase gene. This inborn error of cholesterol synthesis leads to elevated concentrations of 7-dehydrocholesterol (7-DHC). 7-DHC also serves as the precursor for vitamin D synthesis. Limited data is available on vitamin D levels in individuals with SLOS. Due to elevated concentrations of 7-DHC, we hypothesized that vitamin D status would be abnormal and possibly reach toxic levels in patients with SLOS. Through a retrospective analysis of medical records between 1998 and 2006, we assessed markers of vitamin D and calcium metabolism from 53 pediatric SLOS patients and 867 pediatric patients who were admitted to the NIH Clinical Center (NIHCC) during the same time period. SLOS patients had significantly higher levels of 25(OH)D (48.06 ± 19.53 ng/ml, p < 0.01) across all seasons in comparison to the NIHCC pediatric patients (30.51 ± 16.14 ng/ml). Controlling for season and age of blood draw, 25(OH)D levels were, on average, 15.96 ng/ml (95%CI 13.95-17.90) higher in SLOS patients. Although, mean calcium values for both patient cohorts never exceeded the normal clinical reference range (8.6-10.2 mg/dl), the levels were higher in the SLOS cohort (9.49 ± 0.56 mg/dl, p < 0.01) compared to the NIHCC patients (9.25 ± 0.68 mg/dl). Overall, in comparison to the control cohort, individuals with SLOS have significantly higher concentrations of 25(OH)D that may be explained by elevated concentrations of serum 7-DHC. Despite the elevated vitamin D levels, there was no laboratory or clinical evidence of vitamin D toxicity.
Keywords: 7-dehydrocholesterol; Smith-Lemli-Opitz syndrome; metabolic disorder; vitamin D.
© 2017 Wiley Periodicals, Inc.
Conflict of interest statement
The authors of this manuscript have no conflicts of interest to declare.
Figures



References
-
- Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D. Genome-wide association study of circulating vitamin D levels. Human molecular genetics. 2010;19:2739–2745. - PMC - PubMed
-
- Anstey A. Photomedicine: lessons from the Smith-Lemli-Opitz syndrome. Journal of photochemistry and photobiology B, Biology. 2001;62:123–127. - PubMed
-
- Bellone S, Esposito S, Giglione E, Genoni G, Fiorito C, Petri A, Bona G, Prodam F. Vitamin D levels in a paediatric population of normal weight and obese subjects. Journal of endocrinological investigation. 2014;37:805–809. - PubMed
-
- Bonjour JP, Trechsel U, Granzer E, Klopffer G, Muller K, Scholler D. The increase in skin 7-dehydrocholesterol induced by an hypocholesterolemic agent is associated with elevated 25-hydroxyvitamin D3 plasma level. Pflugers Archiv: European journal of physiology. 1987;410:165–168. - PubMed
-
- Charman CR, Ryan A, Tyrrell RM, Pearse AD, Arlett CF, Kurwa HA, Shortland G, Anstey A. Photosensitivity associated with the Smith-Lemli-Opitz syndrome. The British journal of dermatology. 1998;138:885–888. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical